Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts-Reference-Cited by-同舟云学术

Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts

Published:2019-02 Issue: Volume:442 Page:464-474
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Radhakrishnan Rangasudhagar,Ha Ji Hee,Jayaraman Muralidharan^ORCID,Liu Jinsong,Moxley Katherine M.,Isidoro Ciro^ORCID,Sood Anil K.,Song Yong Sang,Dhanasekaran Danny N.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. 'Cancer associated fibroblasts'--more than meets the eye;Madar;Trends Mol. Med.,2013

2. The biology and function of fibroblasts in cancer;Kalluri;Nat. Rev. Canc.,2016

3. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors;Chan;Oncogene,2018

4. A peek into cancer-associated fibroblasts: origins, functions and translational impact;LeBleu;Dis. Model Mech.,2018

5. The role of tumor microenvironment in resistance to anti-angiogenic therapy;Ma;F1000Res,2018

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicompartmentalized Microvascularized Tumor-on-a-Chip to Study Tumor-Stroma Interactions and Drug Resistance in Ovarian Cancer;Cellular and Molecular Bioengineering;2024-09-14

2. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution;Journal of Hematology & Oncology;2024-09-02

3. Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing;Biomarker Research;2024-07-29

4. Autotaxin–Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications;International Journal of Molecular Sciences;2024-07-15

5. Targeting metabolic pathways to counter cancer immunotherapy resistance;Trends in Immunology;2024-07